Rafal Alhatemi, MD (she/her/hers)

Fellow
University of Toledo/ Endocrine Fellowship
Toledo, OH, United States

Disclosure information not submitted.

Presentation(s):

• SAT-610 - Euglycemic Diabetic Ketoacidosis after GLP-1 Receptor Agonist Initiation in A Patient Receiving Chronic SGLT2 Inhibitor Therapy

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-410 - Iodine-Induced Thyrotoxicosis in A Normal Thyroid Gland

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT